cas 4507-57-7|| where to buy methyl 1-aminocyclohexane-1-carboxylate

Produktname:methyl 1-aminocyclohexane-1-carboxylate

IUPAC Name:methyl 1-aminocyclohexane-1-carboxylate

Packungseinheit	Verfügbarer Vorrat	Preis($)	Menge
CM108010-10g	in stock	ȃŹǵ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Zusätzliche Hinweise

Verification code*

refresh

: CAS-Nr.:4507-57-7; Molekulare Formel:C8H15NO2; Schmelzpunkt:-; SMILES-Code:O=C(C1(N)CCCCC1)OC; Dichte:

: Katalognummer:CM108010; Molekulargewicht:157.21; Siedepunkt:209.9°C at 760 mmHg; Mdl-Nr.:MFCD08686793; Lagerung:Keep in a tight container and store at 2°C~8°C，protect from light

: Amino Acids and Peptides; Amino acids are organic compounds containing a basic amino group and an acidic carboxyl group. Because amino acids contain both amino and carboxyl groups, they can be polymerized in an end-to-end manner, removing a molecule of water to form a covalent amide bond or peptide bond. Many amino acids are linked together end to end to form a polypeptide. Amino acids and peptides are important components in the fields of medicine and life sciences.; amino acids wholesale; if you are finding amino acids wholesaler in china, we will be your best choose! We have our own factory, so we can give you a cheap price!

: Cyclohexanes; Cyclohexane is an organic compound with a chemical formula C6H12. It is a colorless liquid with a pungent odor, insoluble in water, and soluble in most organic solvents such as ethanol, ether, benzene, and acetone. Cyclohexyl fragments are a common structure in both natural and synthetic drugs. It can be used as both core structure and part of achiral side chain.

: INX-315; Incyclix Bio announces FDA clearance of investigational new drug application for INX-315 in patients with advanced or metastatic cancer. INX-315 is a novel, potent and selective inhibitor of Cyclin-dependent kinase 2 (CDK2) with compelling pre-clinical efficacy and safety data.
CDK2 is thought to play an important role in driving proliferation of certain cancers, including those harboring CCNE1 amplification and breast cancers that have acquired resistance to CDK4/6 inhibitors (CDK4/6i).